Medicine spending through the next five years will be driven by global COVID-19 vaccinations and new innovations in therapeutic areas such as oncology, according to a new report (bit.ly/3yKYf0k) from the IQVIA Institute for Human Data Science, “The Global Use of Medicines 2023: Outlook to 2027.” However, losses of exclusivity (LOE) and the lower costs of generics and biosimilars will also have a major effect on spending.
COVID-19 vaccines are anticipated to be the